Markets:

Overview

News

Currencies

International

Treasuries

Sage Therapeutics, Inc. - Common Stock (NQ:SAGE)

8.680 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sage Therapeutics, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

What 8 Analyst Ratings Have To Say About Sage Therapeutics ↗

November 03, 2021

Sage Therapeutics (NASDAQ:SAGE) has observed the following analyst ratings ...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

November 03, 2021

Needham boosted Paycom Software, Inc. (NYSE:PAYC) ...

Via Benzinga

Sage Therapeutics Inc (SAGE) Q3 2021 Earnings Call Transcript ↗

November 02, 2021

SAGE earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

How Bad Are Sage Therapeutics's Earnings? | Return On Capital Employed ↗

November 02, 2021

Sage Therapeutics (NASDAQ:SAGE) brought in sales totaling $1.44 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 21.17%, resulting in a...

Via Benzinga

Artificial Intelligence Could Be About To Replace Your Doctor

November 02, 2021

FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – November 2, 2021 – The US health and medical insurance industry is a $1.1-trillion maze that is impossible to navigate. And...

Via FinancialNewsMedia

Topics Artificial Intelligence

Earnings Scheduled For November 2, 2021 ↗

November 02, 2021

Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •...

Via Benzinga

Analyst Ratings For Sage Therapeutics ↗

October 12, 2021

Sage Therapeutics (NASDAQ:SAGE) has observed the following analyst ratings...

Via Benzinga

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗

November 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...

Via Benzinga

Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

November 02, 2021

From Sage Therapeutics, Inc.

Via Business Wire

Preview: Sage Therapeutics's Earnings ↗

November 01, 2021

Sage Therapeutics (NASDAQ:SAGE) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention

October 27, 2021

Palm Beach, FL –October 27, 2021 – FinancialNewsMedia.com News Commentary – Among the race to see what psychedelic drugs can do, ketamine is a step ahead of all other drugs, because it has already been...

Via FinancialNewsMedia

B. Riley Sees 'Significant Potential' In This Beaten-Up Biotech Stock ↗

October 21, 2021

B. Riley analyst calls Seelos Therapeutics Inc (NASDAQ:

Via Benzinga

Sage Therapeutics to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021

October 20, 2021

From Sage Therapeutics, Inc.

Via Business Wire

What 7 Analyst Ratings Have To Say About Sage Therapeutics ↗

October 20, 2021

Sage Therapeutics (NASDAQ:SAGE) has observed the following analyst ratings...

Via Benzinga

Abbot Labs and Biogen Outshine Novavax in the Health Care Sector ↗

October 20, 2021

Just before Tuesday’s close, Netflix (NASDAQ: NFLX) reported better-than-expected earnings by adding 4.4 million subscribers in the third quarter. The company...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

October 20, 2021

Mizuho cut QUALCOMM Incorporated (NASDAQ: QCOM) price target from $180 to $165. QUALCOMM shares fell 0.3% to $132.13 in pre-market trading. Deutsche Bank raised the price...

Via Benzinga

Sage Therapeutics and Biogen Announce Plans to Submit a New Drug Application (NDA) for Zuranolone to the U.S. Food & Drug Administration in the Second Half of 2022 with Rolling Submission Expected to Start in Early 2022

October 19, 2021

From Sage Therapeutics, Inc.

Via Business Wire

A.I. Breakthrough Could Disrupt the $11 Trillion Medical Sector

October 18, 2021

FN Media Group Presents Oilprice.com Market Commentary London – October 18, 2021 – A massive disruption now appears imminent in one of the world’s largest – and most important – industries. In much the...

Via FinancialNewsMedia

Topics Artificial Intelligence

Rising Oil Prices and Yields Makes Market Navigation More Complex ↗

October 05, 2021

Bitcoin (/BTC) topped $50,000 this morning for the first since May, but traders may be more focused on oil prices and yields. Crude oil (/CL) is continuing its rise...

Via Benzinga

Sage Therapeutics and Biogen Announce Consistent Clinically Meaningful Data for Zuranolone Across the LANDSCAPE and NEST Clinical Development Programs Presented at the European College of Neuropsychopharmacology (ECNP) Congress

October 04, 2021

From Sage Therapeutics, Inc.

Via Business Wire

Sage Therapeutics Launches SageCitizen Social Impact Initiative

October 01, 2021

From Sage Therapeutics

Via Business Wire

Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer

September 21, 2021

From Sage Therapeutics

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021 ↗

September 23, 2021

Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:

Via Benzinga

Why Sage Therapeutics Shares Are Trading Higher Today ↗

September 15, 2021

Sage Therapeutics (NASDAQ:SAGE) shares are trading higher after the company announced it received Fast Track Designation for SAGE-718 or the treatment of Huntington's...

Via Benzinga

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Huntington’s Disease

September 15, 2021

From Sage Therapeutics, Inc.

Via Business Wire

Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference

September 02, 2021

From Sage Therapeutics, Inc.

Via Business Wire

5 Value Stocks In The Healthcare Sector ↗

August 23, 2021

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 20, 2021

On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.